Florian Wagenlehner - Concepedia

Author

Florian Wagenlehner

Also Known As

Claudio Viscoli, F M E Wagenlehner, F M Wagenlehner, F M. E. Wagenlehner, F WAGENLEHNER, F Wagenlehner, F. M. E. Wagenlehner, F. M. Wagenlehner, F. Wagenlehner, F.M. Wagenlehner

824

Publications

16.3K

Citations

H-Index

137

Concepts

All Affiliations

Justus-Liebig-Universität Gießen Technical University of Munich Ospedale Santa Chiara Barmherzige Brüder Klinikum St. Elisabeth in Straubing University of Oslo

About

Florian Wagenlehner is an author at Justus-Liebig-Universität Gießen specializing in medicine, urology, and antimicrobial resistance.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	36	80	5K
2	Health Sciences	17	27	1.9K
3	Engineering	1	1	36
4	Language Studies	1	1	17
5	Nursing	1	1	30

Florian Wagenlehner

157

Publications

7.7K

Citations

H-Index

Page 1

	Year	Citations
Guidelines on Urological Infections Magnus Grabe, Riccardo Bartoletti, Tommaso Cai, Urological InfectionsKlebsiella PneumoniaeAntibiotic ResistanceDrug ResistanceUrinary Tract	2009	771
Ceftolozane-tazobactam compared with levofloxacin in the treatment of complicated urinary-tract infections, including pyelonephritis: a randomised, double-blind, phase 3 trial (ASPECT-cUTI) Florian Wagenlehner, Obiamiwe Umeh, Judith N. Steenbergen, The Lancet Urological ResearchUrologyAntibioticsPharmacologyUrinary-tract Infections	2015	372
Ceftazidime-avibactam Versus Doripenem for the Treatment of Complicated Urinary Tract Infections, Including Acute Pyelonephritis: RECAPTURE, a Phase 3 Randomized Trial Program Florian Wagenlehner, Jack D. Sobel, Paul Newell, Clinical Infectious Diseases	2016	338
Once-Daily Plazomicin for Complicated Urinary Tract Infections Florian Wagenlehner, Daniel Cloutier, Allison Komirenko, New England Journal of Medicine UrologyGram-negative UropathogensAntibioticsHealth SciencesBactericidal Activity	2019	205
A Pollen Extract (Cernilton) in Patients with Inflammatory Chronic Prostatitis–Chronic Pelvic Pain Syndrome: A Multicentre, Randomised, Prospective, Double-Blind, Placebo-Controlled Phase 3 Study Florian Wagenlehner, Henning Schneider, M. Ludwig, European Urology Pain DisordersAllergyPlacebo-controlled Phase 3Pain MedicinePain Management	2009	183
Social and economic burden of recurrent urinary tract infections and quality of life: a patient web-based study (GESPRIT) Florian Wagenlehner, Björn Wullt, Stefania Ballarini, Expert Review of Pharmacoeconomics & Outcomes Research	2017	183
Characterization of Escherichia coli Isolates from Hospital Inpatients or Outpatients with Urinary Tract Infection Francisco Toval, Christian-Daniel Köhler, Ulrich Vogel, Journal of Clinical Microbiology Pathogenic MicrobiologyPathogen DetectionUrinary Tract InfectionVirulence TraitsPathology	2013	168
National Institutes of Health Chronic Prostatitis Symptom Index (NIH-CPSI) Symptom Evaluation in Multinational Cohorts of Patients with Chronic Prostatitis/Chronic Pelvic Pain Syndrome Florian Wagenlehner, J. W. Olivier van Till, Vittorio Magri, European Urology Pain SyndromeUrologyPain MedicineDiagnosisMultinational Cohorts	2012	143
Adherence to European Association of Urology Guidelines on Prophylactic Antibiotics: An Important Step in Antimicrobial Stewardship Tommaso Cai, Paolo Verze, Anna Brugnolli, European Urology UrologyPreventive MedicineProphylactic AntibioticsHealth PolicyAntibiotics	2015	138
Non-Antibiotic Herbal Therapy (BNO 1045) versus Antibiotic Therapy (Fosfomycin Trometamol) for the Treatment of Acute Lower Uncomplicated Urinary Tract Infections in Women: A Double-Blind, Parallel-Group, Randomized, Multicentre, Non-Inferiority Phase III Trial Florian Wagenlehner, Dimitri Abramov-Sommariva, Martina Höller, Urologia Internationalis	2018	126

Page 1